NPF Joins MAPRx Coalition Letter Opposing Changes to CMMI Part D Payment Modernization Model

02/15/2021

The Medicare Access for Patients Rx (MAPRx) Coalition is writing in opposition to recent changes, announced on January 19, 2021 under the prior administration, allowing plans to severely limit Part D formularies in the CMS Center for Medicare and Medicaid Innovation (CMMI) Part D Payment Modernization (PDM) Model for plan year 2022. We urge you to rescind these formulary changes, which circumvent current law and allow plans flexibility with the six protected classes and enable plans to significantly restrict drug coverage to one drug per class for all drugs covered under Part D. These changes undermine long-standing beneficiary protections and could, not only limit the ability of beneficiaries to access needed medications, but also jeopardize the health – and in some instances, life - of those with serious and chronic conditions.

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2021 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.